Trump steers the world toward a tax war
FT News Briefing
Tax Warfare and the Rise and Fall of Obesity Drugs
This chapter examines the potential $192 billion annual tax increase proposed under President Trump's influence, with tax experts contesting this figure. It also delves into the pharmaceutical sector's waning interest in obesity drugs following a fervent initial response, analyzing the underlying factors behind this shift.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
